0000818479false00008184792025-05-212025-05-21

WASHINGTON, D.C. 20549

Date of Report (Date of earliest event reported)

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of Principal Executive Offices)

(Zip Code)

(844) 848-0137

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on May 21, 2025. The following matters were voted upon at the Annual Meeting, with the results indicated:

1.Election of eleven directors to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified.

			Director			For			Against			Abstain			Broker Non-Votes
1a.			Michael J. Barber			172,102,362			3,787,179			873,665			11,338,487
1b.			Simon D. Campion			174,843,812			1,063,256			856,138			11,338,487
1c.			Willie A. Deese			168,692,695			7,160,823			909,688			11,338,487
1d.			Brian T. Gladden			174,989,736			922,044			851,426			11,338,487
1e.			Betsy D. Holden			170,692,574			5,210,750			859,882			11,338,487
1f.			Clyde R. Hosein			174,916,436			974,147			872,623			11,338,487
1g			Gregory T. Lucier			172,812,554			3,088,046			862,606			11,338,487
1h.			Jonathan J. Mazelsky			174,487,048			1,403,574			872,584			11,338,487
1i.			Daniel T. Scavilla			172,131,130			3,775,907			856,169			11,338,487
1j.			Leslie F. Varon			174,918,214			983,722			861,270			11,338,487
1k.			Janet S. Vergis			173,988,186			1,915,665			859,355			11,338,487

2.Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2025.

For			Against			Abstain			Broker Non-Votes
187,599,963			409,763			91,967			—

3.Approval, by non-binding advisory vote, of the Company’s executive compensation for 2024.

For			Against			Abstain			Broker Non-Votes
170,911,500			4,944,479			907,227			11,338,487

4.Approval of Amendment No. 1 to the Company’s 2024 Omnibus Incentive Plan (the “2024 Plan”) to increase the number of shares of the Company’s Common Stock issuable under the 2024 Plan by 11,260,000 shares.

For			Against			Abstain			Broker Non-Votes
165,989,940			10,631,325			141,941			11,338,487

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DENTSPLY SIRONA Inc.

Date: May 22, 2025